Rednex Pharmaceuticals Limited

Rednex Pharmaceuticals Limited - pharma in Bavla, Gujarat, India. FY 2026 financials & compliance.
CIN U24304GJ2020PLC119176 Incorporated 29 December 2020 ROC Ahmedabad HQ Bavla, Gujarat, India
Active Public Limited Company pharma DPIIT Startup MSME · Small
Revenue · FY 2025
₹46.14 Cr
▲ 88% YoY
Net profit · FY 2025
₹5.05 Cr
Net margin 10.9%
EBITDA · FY 2025
₹10.56 Cr
EBITDA margin 22.9%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹7.65 Cr
Issued & subscribed
Open charges
₹18.36 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
51
Provident fund records

About Rednex Pharmaceuticals Limited

Data last updated:

Rednex Pharmaceuticals Limited is a public limited company based in Bavla, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2020PLC119176. Its GSTIN is 24AAKCR6961N1ZO (Gujarat).

The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹7.65 Cr. It is led by directors including Chetanbhai Rugnathbhai Matholiya and Jayeshbhai Amarashibhai Sabava.

Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. 586 And 231 Nr. Skf Bearing, Bavla – Bagodara N. H. – 8A Kerala, Gujarat, India – 382220.

As per the financials filed for FY 2025, the company reported a revenue of ₹46.14 Cr, a growth of 88% compared to the previous year. For the same year it recorded a net profit of ₹5.05 Cr (net margin 10.9%) and EBITDA of ₹10.56 Cr (EBITDA margin 22.9%).

The company has about 51 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹18.36 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.

Rednex Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0042686). For more details, the company can be reached via its website rednexpharma.com.

Company details

CIN U24304GJ2020PLC119176
Registration Number 119176
Incorporation Date 29 December 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0042686

CIN history

Rednex Pharmaceuticals has one previous CIN (Corporate Identification Number): U24304GJ2020PTC119176. The current CIN is U24304GJ2020PLC119176, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24304GJ2020PLC119176Current
U24304GJ2020PTC119176Previous

Recognitions & Rankings of Rednex Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0042686

Contact details

Rednex Pharmaceuticals Limited's registered office is in Bavla, Gujarat. Its website is rednexpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Survey No. 586 And 231 Nr. Skf Bearing, Bavla – Bagodara N. H. – 8A Kerala, Gujarat, India – 382220
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Rednex Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Rednex Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rednex Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Rednex Pharmaceuticals Limited, buy the company report.

Financials of Rednex Pharmaceuticals Limited

FY 2025 filings available

Rednex Pharmaceuticals Limited reported revenue of ₹46.14 Cr (up 88% YoY) for FY 2025.

Revenue · FY 2025
₹46.14 Cr ▲ 88%
Net profit · FY 2025
₹5.05 Cr margin 10.9%
EBITDA · FY 2025
₹10.56 Cr margin 22.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 88%
EBITDA CAGR growth
1 year
▲ 121%
3 years · compounded
▲ 521%

Revenue rose 88% in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.56 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.05 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.9%
Net Profit Margin10.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rednex Pharmaceuticals Limited, buy the company report.

Board of directors of Rednex Pharmaceuticals Limited

Rednex Pharmaceuticals has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Chetanbhai Rugnathbhai MatholiyaDirector29 Dec 20205 Years 10 MonthsCurrent
Jayeshbhai Amarashibhai SabavaDirector29 Dec 20205 Years 10 MonthsCurrent
Aakashbhai Mansukhbhai GangadiyaDirector29 Dec 20205 Years 10 MonthsCurrent
Kashyap Naranbhai ThummarDirector16 Sep 20251 Years 2 MonthsCurrent
Narendrabhai Dineshbhai KhambhaliyaDirector01 Sep 20251 Years 2 MonthsCurrent
Rashmi Krunal LakhaniDirector01 Sep 20251 Years 2 MonthsCurrent

Peer comparison

Rednex Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Rhydburg Pharmaceuticals Ltd₹48.17 Cr (FY 2024)26.0%Delhi, India
Edkem Pharmaceuticals Limited₹48.11 Cr (FY 2025)14.0%Ahmedabad, Gujarat, India
Mendine Pharmaceuticals Pvt Ltd₹47.44 Cr (FY 2025)3.0%Kolkata, West Bengal, India
Rednex Pharmaceuticals Limitedthis company₹46.14 Cr (FY 2025)₹5.05 Cr10.9%88.0%51Bavla, Gujarat, India
Subira Pharmaceuticals Private Limited₹45.51 Cr (FY 2024)32.0%Mumbai, Maharashtra, India
Renown Pharmaceuticals Private Limited₹45.41 Cr (FY 2025)12.0%Vadodara, Gujarat, India
Saintlife Pharmaceuticals Limited₹45.01 Cr (FY 2025)26.0%Dehradun, Uttarakhand, India

To see the full peer comparison of Rednex Pharmaceuticals Limited, buy the company report.

Auditor

Rednex Pharmaceuticals Limited is audited by Krupal Bhuva & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Krupal Bhuva & Co.FY 20240146585W

Shareholding

The shareholding of Rednex Pharmaceuticals Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rednex Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹18.36 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹18.36 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Nov 2024101015532State Bank of India₹1.23 CrOpen
09 Sep 2022100609914State Bank of India₹17.13 CrOpen

To see the full charge records of Rednex Pharmaceuticals Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rednex Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Rednex Pharmaceuticals Limited has a workforce of 51 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
51
Active EPFO establishments
1
Employee growth
-12.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2751
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Rednex Pharmaceuticals Limited, buy the company report.

GST

Rednex Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAKCR6961N1ZOGujaratActive02 Mar 2021

To see the full GST registrations and return filing status of Rednex Pharmaceuticals Limited, buy the company report.

Recent activity

Rednex Pharmaceuticals Limited has 6 board changes on record since 2020: 6 appointments. The latest: Kashyap Naranbhai Thummar was appointed as Director on 16 Sep 2025.

Appointed
Kashyap Naranbhai Thummar was appointed as Director.
AGM
Rednex Pharmaceuticals Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Appointed
Narendrabhai Dineshbhai Khambhaliya was appointed as Director.
Appointed
Rashmi Krunal Lakhani was appointed as Director.
Filing
Rednex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with State Bank Of India amounted to Rs. 1.23 Cr with Charge ID 101015532 was registered on 30 Nov 2024.
Charges
A charge with State Bank Of India of Rs. 17.13 Cr registered on 09 Sep 2022 with Charge ID 100609914 was modified on 30 Nov 2024.
Charges
A charge with State Bank Of India amounted to Rs. 17.13 Cr with Charge ID 100609914 was registered on 09 Sep 2022.
Appointed
Aakashbhai Mansukhbhai Gangadiya was appointed as Director.
Appointed
Chetanbhai Rugnathbhai Matholiya was appointed as Director.
Appointed
Jayeshbhai Amarashibhai Sabava was appointed as Director.
Incorporation
29 Dec 2020
Rednex Pharmaceuticals Limited was registered on 29 Dec 2020 with Roc Ahmedabad & aged 5 years 10 months as per MCA records.

Frequently asked questions

Rednex Pharmaceuticals is an active public limited company based in Bavla, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2020 (6+ years old) and is registered under CIN U24304GJ2020PLC119176.

The latest financial statements of Rednex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Rednex Pharmaceuticals is 24AAKCR6961N1ZO, registered in Gujarat.

The CIN (Corporate Identification Number) of Rednex Pharmaceuticals is U24304GJ2020PLC119176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rednex Pharmaceuticals has 4 court cases on record: 4 filed against it. 1 is pending. Most are in the district courts.

Rednex Pharmaceuticals was incorporated on 29 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Rednex Pharmaceuticals by revenue are Rhydburg Pharmaceuticals Ltd, Edkem Pharmaceuticals Limited, Mendine Pharmaceuticals Pvt Ltd, Subira Pharmaceuticals Private Limited, Renown Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kashyap Naranbhai Thummar was appointed as Director on 16 Sep 2025. Narendrabhai Dineshbhai Khambhaliya was appointed as Director on 01 Sep 2025. Rashmi Krunal Lakhani was appointed as Director on 01 Sep 2025. Rednex Pharmaceuticals has 6 board changes on record in total.

Yes, Rednex Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Rednex Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0042686).